-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTINOGEN MEDICAL - XANAMEM SHOWS FAVORABLE SAFETY PROFILE OVER 36 WEEKS WITH NO SERIOUS ADVERSE EVENTS

Reuters·11/19/2026 12:45:00

Please log in to view news